RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Scott Kuwada to Neoplasms

This is a "connection" page, showing publications Scott Kuwada has written about Neoplasms.
Connection Strength

0.470
  1. Li X, Kuang J, Shen Y, Majer MM, Nelson CC, Parsawar K, Heichman KA, Kuwada SK. The atypical histone macroH2A1.2 interacts with HER-2 protein in cancer cells. J Biol Chem. 2012 Jun 29; 287(27):23171-83.
    View in: PubMed
    Score: 0.216
  2. Kuwada SK. Stopping cancer cells in their tracks... Hawaii Med J. 2009 Nov; 68(10):259-60.
    View in: PubMed
    Score: 0.181
  3. Kuwada SK. Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody. Curr Opin Mol Ther. 2007 Feb; 9(1):92-8.
    View in: PubMed
    Score: 0.037
  4. Maul JS, Warner NR, Kuwada SK, Burt RW, Cannon-Albright LA. Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database. Am J Gastroenterol. 2006 Jul; 101(7):1591-6.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support